The 504 HNSCC patients from the cBioPortal database were then clustered into the following two groups: altered group, consisting of patients with IDO1 genetic alterations and unaltered group, consisting of patients without IDO1 genetic alteration. This evidence concerns the gene IDO1 and head and neck squamous cell carcinoma.